ILC 2016 – Dr. Stefano Brillanti - European Medical Journal

Continue

ILC 2016 – Dr. Stefano Brillanti

Hepatology

Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at ILC 2016.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?